How to buy Panacea Acquisition stock (PANA)

Panacea Acquisition is a shell companies business based in the US. Panacea Acquisition shares (PANA) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy Panacea Acquisition stock

Buy Panacea Acquisition stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Panacea Acquisition stock price (NASDAQ: PANA)

Use our graph to track the performance of PANA stocks over time.

Panacea Acquisition shares at a glance

• Key figures

Information last updated 2024-01-24.

52-week range	$0.00 - $0.00
50-day moving average more info button	$10.20
200-day moving average more info button	$9.98
Wall St. target price	N/A
PE ratio more info button	170.6667
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$0.06

Is it a good time to buy Panacea Acquisition stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Panacea Acquisition stock undervalued or overvalued?

Valuing Panacea Acquisition stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Panacea Acquisition's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Panacea Acquisition's P/E ratio

Panacea Acquisition's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 171x. In other words, Panacea Acquisition shares trade at around 171x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Panacea Acquisition financials

Gross profit TTM	$0
Return on assets TTM	-0.35%
Return on equity TTM	0%
Profit margin	0%
Book value	$-0.31
Market Capitalization more info button	$241.1 million

TTM: trailing 12 months

Panacea Acquisition share dividends

We're not expecting Panacea Acquisition to pay a dividend over the next 12 months.

Have Panacea Acquisition's shares ever split?

Panacea Acquisition's shares were split on a 1:10 basis on 7 March 2002 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Panacea Acquisition shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Panacea Acquisition shares which in turn could have impacted Panacea Acquisition's share price.

Panacea Acquisition share price volatility

Over the last 12 months, Panacea Acquisition's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Panacea Acquisition's is 0. This would suggest that Panacea Acquisition's shares are less volatile than average (for this exchange).

Panacea Acquisition overview

Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. Panacea Acquisition Corp. II was incorporated in 2021 and is based in San Francisco, California. .

Frequently asked questions

What percentage of Panacea Acquisition is owned by insiders or institutions?
Currently 3.063% of Panacea Acquisition shares are held by insiders and 97.542% by institutions. When does the fiscal year end for Panacea Acquisition?
Panacea Acquisition's fiscal year ends in December. Where is Panacea Acquisition based?
Panacea Acquisition's address is: 357 Tehama Street, San Francisco, CA, United States, 94103 What is Panacea Acquisition's ISIN number?
Panacea Acquisition's international securities identification number is: KYG6882C1069